Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 147   

Articles published

GSK 1,550.34 -8.16 (-0.52%)
price chart
Last chance to buy GlaxoSmithKline plc for under �16?
GlaxoSmithKline (LSE: GSK) has endured five tough years, with patents expiring on a number of its big money-spinners and competition from generics.
GlaxoSmithKline shares weak despite being on track to deliver its financial ...  Proactive Investors UK
GlaxoSmithKline plc 25.8% Potential Upside Indicated by HSBC  DirectorsTalk Interviews
GlaxoSmithKline Plc (GSK) Q1 2017 Results - Earnings Call Transcript
Thanks, Sheila. Good afternoon, everybody. And a warm welcome to this call in which we're reporting our first quarter results.
This fast-growing pharmaceutical stock blows GlaxoSmithKline plc out of the water
This specialist business, which focuses on attention deficit and hyperactivity disorder, gastrointestinal diseases, human genetic therapies, and regenerative medicine, is a very different beast to pharmaceutical giant GlaxoSmithKline (LSE: GSK). Glaxo ...
Calculating the fair value of GlaxoSmithKline plc (LSE:GSK)
How far off is GlaxoSmithKline (LSE:GSK) to its intrinsic value? I am going to take a look now using a method called discounted cash flow or DCF.
As Price Falls, Vetr Upgrades GlaxoSmithKline To Buy
The Vetr crowd on Thursday upgraded its rating for GlaxoSmithKline plc (ADR) (NYSE: GSK) from 3 stars (Hold), issued 527 days ago, to 4 stars (Buy).
News Buzz GlaxoSmithKline plc (ADR) (NYSE:GSK), CarMax, Inc (NYSE:KMX)  Daily News Journal
Kornitzer Capital Management Trimmed Glaxo Smithkline Adr (GSK) Stake; NASB ...
Is this small-cap growth stock the next GlaxoSmithKline plc?
Small-caps are an excellent way to improve your wealth. Due to the smaller, generally higher-growth nature of small-caps, they tend to produce better returns than bigger blue-chip peers.
Price Target & Session Watch on GlaxoSmithKline PLC (NYSE:GSK)
GlaxoSmithKline PLC (NYSE:GSK) shares traded +0.25% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $47.00 within the next 52-weeks.
GlaxoSmithKline plc (GSK) Earns "Neutral" Rating from JPMorgan ...  The Cerbat Gem
GlaxoSmithKline plc (GSK) Shares Bought by Profund Advisors LLC  Markets Daily
Why I'll likely hold GlaxoSmithKline plc and Diageo plc forever
When it comes to seeking stocks to hold for the long term, two things I look for are long-term 'secular' trends, and sustainable dividend payouts.
GlaxoSmithKline plc (GSK) is an attractive dividend stock, but are there better?
GlaxoSmithKline plc (NYSE:GSK) has pleased shareholders over the past 10 years paying out an average dividend of 4.88% annually.
GlaxoSmithKline plc (GSK) hit its 1-Year High price on 08/02/16  TopChronicle
Fox Run Management LLC Acquires Shares of 15400 GlaxoSmithKline plc (GSK)  Transcript Daily
GlaxoSmithKline plc 6.2% Potential Upside Indicated by JP Morgan Cazenove
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'NEUTRAL' this morning by analysts at JP Morgan Cazenove.
The Credit Suisse Group Reaffirms Neutral Rating for GlaxoSmithKline plc (GSK)  Petro Global News 24